Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization

Author： Crowe J.E.   Bui P.T.   Siber G.R.   Elkins W.R.   Chanock R.M.   Murphy B.R.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.13, Iss.9, 1995-06, pp. : 847-855

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

By Piedra P.A.   Jewell A.M.   Cron S.G.   Atmar R.L.   Paul Glezen W.  

Vaccine, Vol. 21, Iss. 24, 2003-07 ,pp. : 3479-3482

Elsevier

Access to resources Recommend Favorite

Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine

By Herlocher M.L.   Ewasyshyn M.   Sambhara S.   Gharaee-Kermani M.   Cho D.   Lai J.   Klein M.   Maassab H.F.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 172-181

Elsevier

Access to resources Recommend Favorite

Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus

By Hsu K.-H.L.   Crowe J.E.   Lubeck M.D.   Davis A.R.   Hung P.P.   Chanock R.M.   Murphy B.R.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 509-515

Elsevier

Access to resources Recommend Favorite

Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides

By Cano F.   Plotnicky-Gilquin H.   Nguyen T.N.   Liljeqvist S.   Samuelson P.   Bonnefoy J.-Y.   Stahl S.   Robert A.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2743-2752

Elsevier

Access to resources Recommend Favorite

The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B

By Power U.F.   Plotnicky H.   Blaecke A.   Nguyen T.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 168-176

Elsevier

Access to resources Recommend Favorite